Stifel Maintains Buy on Precigen, Maintains $7 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Benjamin Burnett maintains a Buy rating on Precigen (NASDAQ:PGEN) with a $7 price target.

May 15, 2024 | 11:52 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stifel analyst Benjamin Burnett has reiterated a Buy rating on Precigen (NASDAQ:PGEN) and maintained a $7 price target, indicating confidence in the company's future performance.
The reaffirmation of a Buy rating and a $7 price target by a reputable analyst suggests positive sentiment and confidence in Precigen's future performance, likely leading to a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100